Cohen & Steers, Inc.

Cohen & Steers, Inc. (CNS) Market Cap

Cohen & Steers, Inc. has a market capitalization of $4.23B.

Price: $82.27

0.70 (0.86%)

Market Cap: 4.23B

NYSE · time unavailable

CEO: Joseph Martin Harvey

Sector: Financial Services

Industry: Asset Management

IPO Date: 2004-08-16

Website: https://www.cohenandsteers.com

Cohen & Steers, Inc. (CNS) - Company Information

Market Cap: 4.23B|Sector: Financial Services

Company Profile

Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources. Preferred securities also constitute a part of its fixed income portfolios. Established in 1986, Cohen & Steers, Inc. maintains its primary base in New York, with international branch offices in London (UK), Central (Hong Kong), Tokyo (Japan), and Seattle (Washington).

Analyst Sentiment

44%
Hold

From 3 Active Polls

1Y Forecast: $84.00

▲ +2.1% Potential Upside

Consensus Target Metrics

Low Bound

$84

Median

$84

High Bound

$84

Average

$84

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$84.00
▲ +2.10% Upside
Low Target
$84.00
2% Risk
Median Target
$84.00
2% Mid
High Target
$84.00
2% Max
Consensus
Sell
4 / 13 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)4,2293,9253,2183,2173,3793,8554,0974,6974,872
Enterprise Value ($M)4,1703,8653,3013,2103,4213,9014,1724,6554,906
Price to Earnings Ratio (P/E)25.1619.8319.0723.0820.2526.1625.7225.6530.75
Price/Earnings-to-Growth Ratio (PEG)1.439.6315.7014.065.823.29
Price to Sales Ratio (P/S)7.0623.5121.9422.3723.8427.0729.3032.4535.15
Price to Book Ratio (P/B)7.206.665.715.726.147.298.079.189.92
Price to Free Cash Flow Ratio (P/FCF)34.2959.13-62.6457.7464.24-55.26-37.24141.68201.19
Enterprise Value to Sales (EV/Sales)23.1622.5122.3224.1427.3929.8432.1635.39
Enterprise Value to EBITDA (EV/EBITDA)18.4253.6855.2274.9266.1374.3678.1381.4492.51
Debt to Equity Ratio-0.260.240.250.250.270.280.280.29

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 COHEN & STEERS INC (CNS) — Investment Overview

🧩 Business Model Overview

Cohen & Steers is an asset manager focused on real assets and income-oriented strategies, with capabilities concentrated in areas such as real estate securities, infrastructure and related “real asset” exposures, and other targeted income products. The business earns advisory and management economics by translating investment research and portfolio construction into mandates for institutional and retail channels (including vehicles that distribute income and/or use portfolio structures designed for particular investor needs).

The core “how it works” dynamic is relatively straightforward: CNS raises or manages assets for investors, invests those assets using specialized research and active risk management, and receives management fees (and, where applicable, incentive/performance economics). Investor stickiness is supported by mandate-specific implementation, governance process requirements, and the time it takes for investors to evaluate manager fit—creating effective switching costs for many long-duration allocations.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by management fees on assets under management (AUM). A meaningful portion of the firm’s revenue tends to be relatively “recurring” in nature because many client relationships are contractually structured, portfolio allocations are rolled through time, and fee-bearing platforms can persist across market cycles. In addition, CNS can earn incentive/performance-related economics tied to strategy outcomes (depending on fund/mandate terms).

Margin drivers typically include:

  • Fee rate and product mix across real asset and income strategies
  • Operating leverage from research, investment operations, and distribution infrastructure
  • Institutional mandate scalability (research and portfolio management costs are not fully linear with AUM)
  • Revenue stability from strategies designed for ongoing income and portfolio diversification needs

🧠 Competitive Advantages & Market Positioning

CNS’s moat is best characterized as a combination of high switching costs, intangible asset-based expertise, and distribution/relationship durability.

  • High switching costs (mandate specificity): Many institutional investors build allocations through multi-stage due diligence, performance attribution review, operational onboarding, and compliance alignment. Once a manager is selected for a specific strategy profile, replacement is rarely a “quick decision.”
  • Intangible assets (research and implementation): Real assets and income-oriented mandates require domain expertise in security selection, portfolio construction, liquidity management, and downside-risk framing. Competitors can hire talent, but replicating the full operating and investment framework generally takes time.
  • Relationship durability: Manager selection and ongoing reporting cadence can reinforce investor preference, particularly for long-duration allocations.

COMPETITIVE BENCHMARKING (industry comparables):

  • Blackstone: Broad alternative manager spanning private credit, buyouts, and real estate across private markets—more diversified across product types than CNS and often competing with different liquidity structures.
  • Brookfield: Strong global real asset operator and manager with significant emphasis on long-duration real asset platforms; competition may overlap in real estate/infrastructure exposures but with different underlying ownership models.
  • PIMCO: Income-oriented fixed income and multi-sector management; overlaps with CNS on the income-seeking investor base, but CNS’s emphasis on real asset-oriented exposures differentiates its implementation and risk drivers.

Industry focus contrast: CNS tends to emphasize real asset and income strategies with an investment process tailored to those exposures, whereas larger competitors often compete across broader alternative or credit universes with different liquidity terms, capital structures, and investor expectations.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the opportunity set for specialized asset managers like CNS is supported by several structural themes:

  • Ongoing investor demand for income and diversification: Pension plans, endowments, and advisors often seek differentiated income sources and portfolio diversification beyond traditional public equity and core duration exposure.
  • Gradual shift toward alternative-like return drivers: Regulatory and portfolio construction frameworks continue to encourage broader toolkits, increasing demand for real asset exposures and liquid alternatives/income strategies.
  • Global growth of real economy assets: Real estate, infrastructure, and related operating assets expand with global capital formation and urbanization, supporting long-term demand for specialized management of these exposures.
  • Distribution and platform persistence: Once established with distribution partners and institutional allocators, CNS can experience compounding through renewals, incremental mandates, and channel expansions that rely on proven strategy fit.

⚠ Risk Factors to Monitor

  • Market-cycle sensitivity of real asset and credit-linked strategies: Real estate/infrastructure and income strategies can experience drawdowns during credit stress, rising discount rates, or liquidity events.
  • Fee pressure and competitive pricing: Large asset managers and specialist peers may compress fees as markets normalize or as investors demand lower cost structures.
  • Regulatory and structural risks for investment vehicles: Changes in rules governing fund structures, distribution frameworks, disclosures, or leverage/liquidity constraints can affect product economics.
  • Key-person and team stability: Investment performance in specialized strategies can depend on experienced portfolio management teams and research continuity.
  • Liquidity and valuation mechanics: Real asset exposure can carry complex valuation and liquidity dynamics that become more consequential in stressed conditions.

📊 Valuation & Market View

Asset managers are typically valued on a combination of earnings power and balance of recurring revenue quality, with market frameworks often referencing:

  • Multiples of earnings (e.g., P/E) reflecting profitability and durability
  • EV/EBITDA or similar operating valuation measures reflecting operating leverage
  • Economics relative to AUM (investor focus on fee rate, expense discipline, and revenue stability)

For CNS specifically, valuation tends to be most sensitive to the perceived sustainability of fee-bearing AUM, operating leverage from fixed-cost research/distribution investments, and the market’s view of strategy differentiation versus broader alternative managers.

🔍 Investment Takeaway

Cohen & Steers presents a long-term, structural thesis as a specialized alternative/income manager: its competitive edge is rooted in high switching costs from mandate governance and investor selection processes, supported by intangible expertise in real asset and income strategy construction. While results can fluctuate with real asset and credit cycles, the firm’s differentiated strategy focus and relationship durability provide a credible foundation for compounding through fee-bearing AUM growth and operating leverage over a full market cycle.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CNS.

globenewswire.com2026-07-31

Cerenome Launches as an Integrated CNS Oncology Company

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announces that its corporate rebrand to Cerenome will be completed as scheduled. Effective August 3, 2026, the Company's name will become Cerenome, Inc. The Company's common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “CNSY,” effective market open on the same day.

prnewswire.com2026-07-30

Cohen & Steers, Inc. Declares Quarterly Dividend

NEW YORK, July 30, 2026 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the third quarter of 2026 in the amount of $0.67 per share of common stock payable on August 20, 2026 to stockholders of record as of the close of business on August 10, 2026. About Cohen & Steers.

zacks.com2026-07-30

AMG or CNS: Which Is the Better Value Stock Right Now?

Investors with an interest in Financial - Investment Management stocks have likely encountered both Affiliated Managers Group (AMG) and Cohen & Steers Inc (CNS). But which of these two stocks offers value investors a better bang for their buck right now?

prnewswire.com2026-07-29

Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy

NEW YORK, July 29, 2026 /PRNewswire/ -- Cohen & Steers Closed-end Opportunity Fund, Inc. (NYSE:FOF) (the "Fund"), announced today that the Fund's Board of Directors has approved certain changes to the Fund's 80% investment policy and related investment strategy disclosure. The changes will be effective October 1, 2026 (the "Effective Time").

prnewswire.com2026-07-28

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com2026-07-28

Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com2026-07-28

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com2026-07-28

Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com2026-07-28

Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

globenewswire.com2026-07-28

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

HOUSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing targeted therapeutics and diagnostics for central nervous system (“CNS”) cancers, today announced two posters highlighting its ReSPECT-LM clinical development program and CNSide® cerebrospinal fluid (“CSF”) diagnostic platform will be presented at the 2026 Society for Neuro-Oncology/American Society of Clinical Oncology (“SNO/ASCO”) CNS Metastases Conference, being held August 13–15, 2026, in Boston, Massachusetts. The Company and its wholly owned subsidiary, CNSide Diagnostics, LLC, will also host a sponsored symposium titled “Redefining the Management of Leptomeningeal Metastases: Integrating Diagnostics, Molecular Insights, and Emerging Therapies” on Thursday evening, August 13, 2026.

defenseworld.net2026-07-27

Gabelli Funds LLC Has $11.91 Million Position in Cohen & Steers Inc $CNS

Gabelli Funds LLC lifted its position in Cohen and Steers Inc (NYSE: CNS) by 38.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 190,395 shares of the asset manager's stock after buying an additional 52,400 shares during the quarter. Gabelli

gurufocus.com2026-07-23

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Adv

globenewswire.com2026-07-21

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, July 21, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of  Plus Therapeutics, Inc.  (Nasdaq:  PSTV ) (“Plus” or the “Company”), announced today that it has signed a regional agreement with Medical Mutual effective July 1, 2026, covering approximately 1.2 million people throughout Ohio and Kentucky, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay. This brings CNSide CSF TCE assay total contracted coverage to approximately 127 million people.

prnewswire.com2026-07-20

Cohen & Steers Appoints Erik Schneberger as Chief Marketing Officer

NEW YORK, July 20, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the appointment of Erik Schneberger as Executive Vice President, Chief Marketing Officer. Based in New York, Mr.

seekingalpha.com2026-07-17

Cohen & Steers Q2: Rally Reflects Improving Real Estate Flows (Downgrade)

Cohen & Steers, Inc. is now rated Hold after a strong rally closed the prior valuation gap. CNS's Q2 saw net inflows of $1.3B and AUM rise to $100.1B, signaling renewed interest in public real estate. Operating margin expanded to 36.3% on revenue growth, with scope to reach 37% in H2 if markets remain stable.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"CNS reported Q1’26 revenue of $146.65M and net income of $42.37M (EPS: $0.82). Revenue rose QoQ to $146.65M vs. $143.80M in Q4’25 (+2.0% QoQ) and grew YoY from $139.84M in Q1’25 (+4.8% YoY). Net income increased QoQ from $34.88M to $42.37M (+21.5% QoQ) and was down YoY from $39.78M (+6.5% YoY). Profitability improved versus the prior quarter: gross margin expanded to 85.3% (from 82.1% in Q4’25), while net margin increased to 28.9% (from 24.3% in Q4’25). Over the last four quarters, margins appear more volatile than steadily improving, but Q1’26 is clearly stronger than Q4’25. Cash flow quality weakened materially: operating cash flow was -$51.4M and free cash flow was -$51.4M, driven by a large working-capital outflow (change in working capital of -$115.0M). Despite this, balance-sheet liquidity remains very strong—cash and equivalents increased to $53.1M while total assets rose to $854.7M, with equity stable at $667.0M. Dividend payments were substantial (-$34.5M in the quarter), and buybacks were modest (-$16.9M), but the current quarter’s negative operating cash flow raises near-term coverage risk. Shareholder returns based on provided market data are mixed: price is $66.67 with 1y_change of -9.77% (no >20% momentum). Total return support comes more from yield (dividend yield ~1.07%) than from price appreciation. Analyst valuation context: consensus price target is $76 vs. $66.67 (~14% upside), suggesting moderate optimism."

Revenue Growth

Positive

Q1’26 revenue $146.65M: +2.0% QoQ (+4.8% YoY vs. Q1’25 $139.84M). Growth is positive but not accelerating.

Profitability

Positive

Net margin improved to 28.9% in Q1’26 (from 24.3% in Q4’25). Net income +21.5% QoQ to $42.37M, but YoY net income is +6.5% (up from $39.78M).

Cash Flow Quality

Neutral

Operating cash flow was -$51.4M and free cash flow -$51.4M in Q1’26, mainly due to working-capital outflows (-$115.0M). Dividends of -$34.5M in the quarter plus weak cash generation reduces near-term quality/coverage.

Leverage & Balance Sheet

Good

Balance sheet remains resilient: total assets $854.7M and total equity $667.0M in Q1’26. Debt is moderate (total debt $136.3M; net debt $83.2M), and equity is stable versus prior quarters.

Shareholder Returns

Fair

1y price change is -9.77% (no strong momentum). Dividend yield is ~1.07% with ongoing payouts, while buybacks were modest (-$16.9M). Total shareholder return likely lagged due to price decline.

Analyst Sentiment & Valuation

Positive

Consensus price target $76 vs. $66.67 current (~14% upside). Indicates constructive sentiment, assuming profitability and cash generation normalize.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

CNS reported strong Q2 momentum: adjusted EPS of $0.85, operating margin expanding to 36.3%, and net inflows of $1.3B—the best flow quarter in 4.5 years—on AUM growth of ~8% to over $100B. The earnings quality is reinforced by revenue growth (+5%) outpacing expenses (+3%), with management maintaining expense/compensation guidance (comp ~40% of revenues; tax rate 25%-26%). The core narrative is capital returning to real assets as investors rotate toward REIT fundamentals and infrastructure’s AI/power investment cycle. In Q&A, management stressed pipeline resilience (won/unfunded ~$1.7B ± for four quarters) and “velocity” improvements, with early international allocation wins. On the business development side, ETF adoption is progressing (active ETF AUM >$1B; wirehouse onboarding started) and distribution operations are being restructured via a new COO role. Near-term performance risk is mainly tied to cell tower REIT positioning, while Japan sub-advisory remains a localized headwind.

AI IconGrowth Catalysts

  • U.S. Real Estate led net inflows ($833M) and management expects improving demand as REITs show rotation/recognition of fundamentals
  • Global listed infrastructure maintains momentum with a sixth straight quarter of inflows, benefiting from AI/power capital investment cycle
  • Multi-strategy real assets benefited from persistent inflation; strategy-wide AUM reached $3B and grew at a 29% CAGR since 2021
  • Preferred securities strategy delivered a second consecutive quarter of inflows; low-duration preferred led flows
  • Active ETFs surpassed $1B AUM; expected ETF expansion includes multi-strategy real assets version by end of summer

Business Development

  • UBS managed the rights offering for Cohen & Steers Quality Income Fund (RQI); increased AUM by $220M expected from $154M raised including leverage
  • Tactical Real Estate LP (TREF) uses IDR’s indexed approach to core private real estate funds combined with Cohen & Steers active REIT strategy
  • ETF adoption efforts: onboarding at wirehouses began (U.S. Real Estate Fund and Preferred Stock Fund referenced)
  • SICAV wealth platform (Luxembourg domicile) showed greatest SICAV flows in the multi-strategy real assets portfolio
  • Sub-advisory pipeline includes initiatives/mandates referenced in Canada, Australia, New Zealand, and Korea (Japan noted as a challenge)

AI IconFinancial Highlights

  • Adjusted EPS: $0.85 (up from $0.79 in Q1 2026 and $0.73 in Q2 2025)
  • AUM: increased ~8% to over $100B (positive market performance + strong net inflows)
  • Net inflows: $1.3B (highest in 4.5 years; seventh inflow quarter in past eight); institutional pipeline $1.6B
  • Operating margin improved to 36.3% (benefit from higher revenues as business scales)
  • Revenue: up 5% to $152M (driven by higher average AUM from appreciation + inflows)
  • Operating expenses: up 3% to $97M (incentive comp accruals); expense growth below revenue growth supporting margin expansion
  • Guidance/expense mix maintained: compensation & benefits ~40% of revenues; G&A mid-single-digit growth vs 2025; pro forma effective tax rate 25%-26%
  • Liquidity: $219M in U.S. Treasuries and ~$136M of liquid seed investments

AI IconCapital Funding

  • RQI rights offering (closed-end fund): $154M raised including associated leverage; management expects it to increase AUM by $220M; second rights offering executed in the past year
  • No buyback/debt level amounts were provided in the transcript; cash and seed investment levels cited instead ($219M Treasuries; ~$136M liquid seed)

AI IconStrategy & Ops

  • Automation/operations: created a new Chief Operating Officer role led by Amanda Eikas to run distribution operations under Dan Noonan, improving distribution operational efficiency
  • Sub-advisory growth initiative leadership: Matt Pace to lead growth initiative; opportunities cited in U.S., Canada, Australia, New Zealand; potential in Korea; Japan currently challenged due to bond yield/macro and strong equity appetite
  • Distribution platform milestones: approaching three-year anniversary of non-traded REIT; highest non-seed subscription level last month; non-traded REIT referenced as outperforming peer average by 760 bps since inception
  • ETF conversion rationale: Future of Energy open-end fund (~$170M AUM) converted to ETF CSEN due to weak distribution take-up and platform risk; conversion avoided 401(k) exposure loss; a major wirehouse doubled down and increased recommendation

AI IconMarket Outlook

  • U.S. REIT outlook: management expects reversion to historical norm of 200 bps of alpha going forward after near-term cell tower-related underperformance
  • Real estate listed outlook: dividend yields 3%-4%, earning growth above historical norm of 6%, and management expects double-digit returns for listed real estate strategies even at current/modestly higher rates
  • Launch timing: by the fall, management expects to launch its seventh ETF (multi-strategy real assets version); goal stated that core strategies move into ETF vehicle by end-of-summer for the multi-strategy real assets portfolio

AI IconRisks & Headwinds

  • U.S. REIT one-year underperformance was attributed to positioning in cell tower REITs impacted by slowdown in carrier spending after initial 5G build-out
  • Risk framing: management cited overblown fears that satellite will displace towers; implies valuation/performance sensitivity remains
  • Japan sub-advisory headwind: challenged by Japan macro with bond yields up meaningfully and strong appetite for equities
  • Private real estate fundraising and wealth flows still challenging; management quantified private real estate fundraising down about 5% annualized this year
  • Private credit liquidity/credit standards and crowding concerns persist, driving shifting advisor allocations (a tailwind for real assets but a macro risk)

Q&A: Analyst Interest

  • Topic: Real estate demand (wealth + institutional) and pipeline sustainability: Management linked U.S. real estate leadership in wealth flows to improving institutional interest, cited won/unfunded pipeline stability (~$1.7B ±) across four quarters, and emphasized good pipeline “velocity” (fundings/replacements) with growing international domiciles.
  • Topic: International distribution traction and what must change for non-U.S. growth: Management outlined three levers—SICAV wealth channel (Luxembourg-domiciled offshore open-end funds), core institutional pipeline mandates, and global sub-advisory—then cited greatest SICAV flows year-to-date in U.K., Japan, and South Africa and noted ongoing investment plus more progress needed.
  • Topic: ETF distribution adoption, broker-dealer placement, advisor usage, and fee/margin impacts: Management described a staged model—seeding, then RIA adoption and wirehouse onboarding—cited early placements in U.S. Real Estate and Preferred Stock ETFs, stated pricing at a slight discount to lowest-cost open-end share classes (net vs overall fee rates ~58%-59%), and targeted all core strategies in ETFs by end-of-summer.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the CNS Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CNS.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (CNS)

© 2026 Stock Market Info — Cohen & Steers, Inc. (CNS) Financial Profile